# Intensive Statin Treatment in Chinese Coronary Artery Disease Patients Undergoing PCI

Study · id `cardio:ct-nct01293097` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01293097](<https://clinicaltrials.gov/study/NCT01293097>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01293097

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2884 participants.

## Technical summary

Registry record NCT01293097. Randomized; no masking; primary purpose treatment. Start 2010-06 (registry gives no type); primary completion 2011-10 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 2884 participants (enrolled count; ClinicalTrials.gov record NCT01293097, source copy `cardio:ctgov-nct01293097-2013-04-30`, retrieved 2026-10-31)
- Start date: 2010-06 (registry gives no type) (ClinicalTrials.gov record NCT01293097, source copy `cardio:ctgov-nct01293097-2013-04-30`, retrieved 2026-10-31)
- Primary completion: 2011-10 (actual) (ClinicalTrials.gov record NCT01293097, source copy `cardio:ctgov-nct01293097-2013-04-30`, retrieved 2026-10-31)
- Completion: 2011-10 (actual) (ClinicalTrials.gov record NCT01293097, source copy `cardio:ctgov-nct01293097-2013-04-30`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT01293097, source copy `cardio:ctgov-nct01293097-2013-04-30`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01293097-2013-04-30`, retrieved 2026-10-31)

## The registry's words

- Brief title: Intensive Statin Treatment in Chinese Coronary Artery Disease Patients Undergoing PCI
- Acronym: ISCAP
- Condition: Non-ST Segment Elevation Myocardial Infarction
- Condition: Unstable Angina Pectoris
- Condition: Stable Angina Pectoris
- Intervention (Drug): Atorvastatin
- Intervention (Drug): Statin
- Lead sponsor: Peking University First Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Stable angina (`cardio:stable-angina`)
- Registry condition terms include this condition: Unstable angina (`cardio:unstable-angina`)
- Registry intervention name matches this record: Atorvastatin (`cardio:atorvastatin`)
- Registry intervention is a member of this class by a sourced record link: Statins (`cardio:statins`)
- Registry lists this organization as the lead sponsor: Peking University First Hospital (`cardio:org-peking-university-first-hospital`)

## Provenance

Content hash: c04c178e3a2800396f1bcc4da424cc78ccc0a0873c7355faa6c864b291c1c21d
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
